Blinatumomab Antibody Molecule
by Alfred Pasieka
Title
Blinatumomab Antibody Molecule
Artist
Alfred Pasieka
Medium
Photograph - Photograph
Description
Schematic computer artwork of the monoclonal antibody Blinatumomab, a bi-specific T-cell engager (BiTE). Blinatumomab (trade name) specifically targets the CD19 antigen present on B cells. Blinatumomab enables a patient's T cells to recognize malignant B cells. A molecule of blinatumomab combines two binding sites: a CD3 site for T cells and a CD19 site for the target B cells. CD3 is part of the T cell receptor. The drug works by linking these two cell types and activating the T cell to exert cytotoxic activity on the target cell.Blinatumomab is used as a second-line treatment against acute lymphoblastic leukemia. The background is depicting a cancer cell.
Uploaded
July 2nd, 2016
Statistics
Viewed 656 Times - Last Visitor from New York, NY on 03/28/2024 at 6:58 PM
Embed
Share
Sales Sheet
Comments
There are no comments for Blinatumomab Antibody Molecule. Click here to post the first comment.